14 Feb 2025
BCNA Policy Priorities 2025
Everyday in Australia, 58 people are diagnosed with breast cancer and 9 lives are lost. Despite many advances in research and treatment, it continues to be the most common cancer affecting Australian women and costs the Australian Government nearly $1.8 billion annually.
30 Jan 2025
BCNA calls for prioritisation of genetic discrimination legislation
In September 2024, Assistant Treasurer and Minister for Financial Services, the Hon Stephen Jones MP, announced that the Federal Government would introduce a total legislative ban on genetic discrimination in life insurance, and that this would be introduced in the current parliamentary term.
17 Jan 2025
Research shows exercise improves quality of life for people with metastatic breast cancer
New research shows that a regular, supervised exercise program can make a significant difference for people living with metastatic breast cancer.
20 Nov 2024
BCNA joins Advisory Group to shape generational reform in health technology assessment
The Albanese Government has announced the formation of the Health Technology Assessment (HTA) Review Implementation Advisory Group (IAG), marking a significant step toward generational reform in Australia’s healthcare system.
16 Oct 2024
New data captures true numbers for metastatic breast cancer
In a world first, people with metastatic breast cancer are now being counted – at least in New South Wales. And work by the Cancer Institute New South Wales shows numbers have been wildly underestimated.
09 Sep 2024
Dealing with fear or doubt about treatment choices
When public figures share their personal healthcare choices, media coverage can be valuable to draw attention to important issues and start discussions in the community.
04 Sep 2024
BCNA statement about Elle Macpherson's treatment decisions
Breast Cancer Network Australia (BCNA) would like to address recent media coverage regarding
28 Aug 2024
Greater access to life-extending drug for people with metastatic breast cancer
In a significant decision set to benefit around 1,700 people each year, access to cancer drug trastuzumab deruxtecan (Enhertu) is being expanded from 1 September 2024.
15 Aug 2024
BCNA celebrates cancer nurses and advocates for enhanced support on Cancer Nurses Day
Their expertise, compassion, and unwavering commitment ensure that patients receive not only the best clinical care but also the emotional and psycho-social support crucial to navigating their cancer experience.
